| Tacrine-based Multifunctional Agents in Alzheimer's Disease: An Old Story in Continuous Development § A Milelli, A De Simone, N Ticchi, H H Chen, N Betari, V Andrisano, ... Current Medicinal Chemistry 24 (32), 3522-3546, 2017 | 57 | 2017 |
| Design, synthesis and multitarget biological profiling of second-generation anti-Alzheimer rhein–huprine hybrids FJ Pérez-Areales, N Betari, A Viayna, C Pont, A Espargaro, M Bartolini, ... Future Medicinal Chemistry 9 (10), 965-981, 2017 | 51 | 2017 |
| Discovery of the first-in-class GSK-3β/HDAC dual inhibitor as disease-modifying agent to combat Alzheimer’s disease A De Simone, V La Pietra, N Betari, N Petragnani, M Conte, S Daniele, ... ACS Medicinal Chemistry Letters 10 (4), 469-474, 2019 | 46 | 2019 |
| ADHD symptoms in neurometabolic diseases: Underlying mechanisms and clinical implications SC Homaei, H Barone, R Kleppe, N Betari, A Reif, J Haavik Neuroscience & biobehavioral reviews 132, 838-856, 2022 | 33 | 2022 |
| Targeting topoisomerase II with trypthantrin derivatives: Discovery of 7-((2-(dimethylamino) ethyl) amino) indolo [2, 1-b] quinazoline-6, 12-dione as an antiproliferative agent … E Catanzaro, N Betari, JM Arencibia, S Montanari, C Sissi, A De Simone, ... European Journal of Medicinal Chemistry 202, 112504, 2020 | 28 | 2020 |
| Naphthalene diimide-polyamine hybrids as antiproliferative agents: Focus on the architecture of the polyamine chains A Milelli, C Marchetti, ML Greco, F Moraca, G Costa, E Turrini, ... European Journal of Medicinal Chemistry 128, 107-122, 2017 | 21 | 2017 |
| Inhibition of Tryptophan Hydroxylases and Monoamine Oxidase-A by the Proton Pump Inhibitor, Omeprazole—In Vitro and In Vivo Investigations N Betari, K Sahlholm, X Morató, H Godoy-Marín, O Jáuregui, K Teigen, ... Frontiers in Pharmacology 11, 593416, 2020 | 13 | 2020 |
| Discovery and biological characterization of a novel scaffold for potent inhibitors of peripheral serotonin synthesis N Betari, K Sahlholm, Y Ishizuka, K Teigen, J Haavik Future Medicinal Chemistry 12 (16), 1461-1474, 2020 | 10 | 2020 |
| In vitro comparison of ulotaront (SEP-363856) and ralmitaront (RO6889450): two TAAR1 agonist candidate antipsychotics R Ågren, N Betari, M Saarinen, H Zeberg, P Svenningsson, K Sahlholm International Journal of Neuropsychopharmacology 26 (9), 599-606, 2023 | 5 | 2023 |
| Dopamine-induced arrestin recruitment and desensitization of the dopamine D4 receptor is regulated by G protein-coupled receptor kinase-2 V Burström, R Ågren, N Betari, M Valle-León, E Garro-Martínez, F Ciruela, ... Frontiers in Pharmacology 14, 1087171, 2023 | 4 | 2023 |
| Synthetic corticosteroids as tryptophan hydroxylase stabilizers N Betari, K Teigen, K Sahlholm, J Haavik Future Medicinal Chemistry 13 (17), 1465-1474, 2021 | 3 | 2021 |
| Pharmacological Characterization of Potent Human Trace Amine-Associated Receptor 1 (TAAR1) Agonists M Saarinen, A Diaz, R Agren, N Betari, H Zeberg, K Sahlholm, J Carlsson, ... NEUROPSYCHOPHARMACOLOGY 48, 391-391, 2023 | | 2023 |
| Design, Synthesis and Biological Evaluation of New Agents for the Treatments of Chronic Degenerative Diseases N Betari alma, 2017 | | 2017 |
